Achievement of a negative minimal residual disease state after hypomethylating agent therapy in older patients with AML reduces the risk of relapse
P Boddu; J Jorgensen; H Kantarjian; G Borthakur; T Kadia; N Daver; Y Alvarado; N Pemmaraju; P Bose; K Naqvi; M Yilmaz; S Pierce; M Brandt; C D DiNardo; E J Jabbour; M Konopleva; G Garcia-Manero; J Cortes; F Ravandi
Author Information: Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA and
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.